PEDIATRICS Vol. 88 No. 2 August 1991, pp. 236-241
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nemir, R. L.
Right arrow Articles by O'Hare, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nemir, R. L.
Right arrow Articles by O'Hare, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Tuberculosis in Children 10 Years of Age and Younger: Three Decades of Experience During the Chemotherapeutic Era

Rosa Lee Nemir MD1 and Donna O'Hare MD1

1 From the Children's Chest Clinic of Bellevue Hospital and Department of Pediatrics, New York University Medical Center, New York, New York

The 863 patients, aged 10 years and younger, treated at the Children's Chest Clinic of Bellevue Hospital during three decades (1953 through 1981) clearly indicated the success of antituberculosis therapy. There were no deaths from tuberculosis. Early treatment is associated with a reduction in the serious forms of disease, eg, meningitis, miliary disease, and bone infections, and with preventing death. Medication was well tolerated: only 1.1% of the patients had adverse reactions, all of which were reversible. Consistent compliance with medication of only 62% of patients is a challenge to the medical profession. Only 22.5% of mycobacterial cultures were positive. Long-term follow-up of patients was rewarding: seven pregnancies with healthy mothers and babies, and no reactivation of tuberculosis by later infections, even those such as measles or pneumonia. The severity of disease was related largely to patient's age (3 years and younger) and intimacy of contact, the highest rate being when the mother was the contact. The long-term experience emphasizes the value of early identification, therapeutic compliance, and comprehensive contact tracing in the future elimination of tuberculosis. Prophylactic therapy and close observation should be considered for contacts, especially those exposed to human immunodeficiency virus infections and addicted to drugs.

Key Words: tuberculosis • rifampin • iaoniazid • follow-up

Submitted on August 2, 1990
Accepted on October 19, 1990


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 ChestHome page
J. M. Merino, T. Alvarez, M. Marrero, S. Anso, A. Elvira, G. Iglesias, and J. B. Gonzalez
Microbiology of Pediatric Primary Pulmonary Tuberculosis
Chest, May 1, 2001; 119(5): 1434 - 1438.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. M. De Cock, B. Soro, I. M. Coulibaly, and S. B. Lucas
Tuberculosis and HIV Infection in Sub-Saharan Africa
JAMA, September 23, 1992; 268(12): 1581 - 1587.
[Abstract] [PDF]

Home page
 Arch Fam MedHome page
N. C. Elder
Extrapulmonary Tuberculosis: A Review
Arch Fam Med, September 1, 1992; 1(1): 91 - 98.
[Abstract] [PDF]